← Insider buys
RVNC

Revance Therapeutics, Inc.

CFO, CBO, Secretary Lauren P Silvernail sold $36K of Revance Therapeutics, Inc.

Sold$36,212
$20.20Price
1,793Shares
−5%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, May 22. Filed Wed, May 24, 5:14 PM ET, after the close. Not investment advice.